Jun 5, 2020

Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?

The Journal of urology

Dominik Deniffel, Emmanuel Salinas, Marc Ientilucci, Andrew J Evans, Neil Fleshner, Sangeet Ghai, Robert Hamilton, Alexander Roberts, Ants Toi, Theodorus van der Kwast, Alexandre Zlotta, Antonio Finelli, Masoom A Haider, Nathan Perlis

CONCLUSIONS: Men with positive multiparametric magnetic resonance imaging and GG1 prostate cancer on magnetic resonance imaging targeted biopsy are at increased risk for intervention, upgrading and unfavorable disease at radical prostatectomy compared to those with multiparametric magnetic resonance imaging invisible GG1 prostate cancer.

Read Article

Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?

Share This